import sys
from pathlib import Path
import pytest

ROOT = Path(__file__).parents[1]
sys.path.append(str(ROOT))


from pydantic import (
    Field,
    BaseModel,
    validator,
    ConfigDict,
    field_validator,
    field_serializer,
    model_validator,
    ValidationError,
)

from desci_sense.shared_functions.schema.post import (
    RefPost,
    ThreadRefPost,
    QuoteRefPost,
)
from desci_sense.shared_functions.interface import (
    AppThread,
    ParsePostRequest,
    Author,
    AppPost,
)
from desci_sense.shared_functions.dataloaders import scrape_post
from desci_sense.shared_functions.dataloaders.twitter.twitter_utils import (
    extract_external_ref_urls,
    scrape_tweet,
    extract_twitter_status_id,
)
from desci_sense.shared_functions.preprocessing import (
    convert_thread_interface_to_ref_post,
    convert_app_post_to_ref_post,
    convert_app_post_to_quote_ref_post,
    ParserInput,
    preproc_parser_input,
)

QUOTED_THREAD_I123 = {
    "author": {
        "platformId": "twitter",
        "id": "author_123",
        "username": "user123",
        "name": "John Doe",
    },
    "url": "https://x.com/fchollet/status/1810833882037825646",
    "thread": [
        {
            "url": "https://x.com/fchollet/status/1810833882037825646",
            "content": "The fact is that tech bubbles have very little to do with the technical or even commercial merits of the technology they form around. They can happen with worthless narratives or with entirely grounded ones. They don't even require unrealistic revenue projections!",
        }
    ],
}

TEST_POST_I123 = {
    "author": {
        "platformId": "twitter",
        "id": "author_456",
        "username": "user546",
        "name": "Sarah Gore",
    },
    "url": "https://example.com/post/2",
    "thread": [
        {
            "url": "https://example.com/post/2",
            "content": "Something deep alluded to here: - In theory we have free markets as superhuman information processors (Hayek) - In practice, that information processing is limited by the bounded, fallible & biased cognition of individual investors wielding outsized influence https://twitter.com/fchollet/status/1810833882037825646",
            "quotedThread": QUOTED_THREAD_I123,
        }
    ],
}


TEST_THREAD_INTERFACE_2 = {
    "url": "https://example.com/post/2",
    "thread": [
        {
            "url": "https://example.com/post/2",
            "content": "This is the first post in the thread.",
        },
        {
            "url": "https://example.com/post/3",
            "content": "This is the second post in the thread.",
        },
    ],
    "author": {
        "platformId": "twitter",
        "id": "author_456",
        "username": "user546",
        "name": "Sarah Gore",
    },
}

TEST_THREAD_INTERFACE_1 = {
    "url": "https://example.com/post/1",
    "thread": [
        {
            "url": "https://example.com/post/1",
            "content": "This is the first post in the thread.",
            "quotedThread": TEST_THREAD_INTERFACE_2,
        },
        {
            "url": "https://example.com/post/2",
            "content": "This is the second post in the thread.",
        },
    ],
    "author": {
        "platformId": "twitter",
        "id": "author_123",
        "username": "user123",
        "name": "John Doe",
    },
}

TEST_OVERLENGTH_THREAD_INTERFACE = {
    "url": "https://example.com/post/2",
    "thread": [
        {
            "url": "https://example.com/post/2",
            "content": "This is the first post in the thread.",
        },
        {
            "url": "https://example.com/post/3",
            "content": ",".join([str(x) for x in range(3000)]),
        },
    ],
    "author": {
        "platformId": "twitter",
        "id": "author_456",
        "username": "user546",
        "name": "Sarah Gore",
    },
}


SINGLE_QUOTE_TWEET = {
    "url": "https://x.com/nnnn/status/180089896680621",
    "content": "The Brazilian Congress will consider a bill to protect Brazilian creators &amp; defend its diverse cultural heritage by preventing unauthorized use of creative works to train AI. Vital that @laerciosergipe’s amendment that would reverse this be defeated.\n@RicardoJuchem @claudiopozas https://twitter.com/arteesetica/status/1800630415780192665",
    "author": {
        "id": "246",
        "name": "nttt",
        "username": "nnnn",
        "platformId": "twitter",
    },
    "quotedPosts": [
        {
            "url": "https://x.com/Arte/status/198966806216849",
            "content": "BRASIL 🇧🇷 Se votará un proyecto de ley para regular el uso de la IA. En la audiencia pública previa se exigió transparencia, trazabilidad, respeto a los derechos de autor, REGULACIÓN y se hizo hincapié en la pérdida de empleos a partir de la irrupción de esta tecnología. https://twitter.com/ArteEsEtica/status/1800630415780192665/photo/1 https://twitter.com/claudiopozas/status/1800563300822057219",
            "author": {
                "id": "162746500",
                "name": "ARTE es ÉTICA",
                "username": "Arte",
                "platformId": "twitter",
            },
        }
    ],
}


MULTI_QUOTE_THREAD = {
    "url": "https://x.com/JohnDoe/status/1798166864398271",
    "content": "After careful consideration, the FDA advisory commission voted today 9:2 that MDMA has *not* been shown to be effective for treating PTSD, given massive concerns around validity threats in this literature. They also voted 10:1 that MDMA has *not* shown to be safe. https://twitter.com/FDAadcomms/status/1798104612635070611\n---\n📄Many mentioned reasons overlap with those we summarized recently in our review paper: \nhttps://journals.sagepub.com/doi/10.1177/20451253231198466\n\n📺 I also summarize them for a lay audience in this YouTube video: \nhttps://youtu.be/WknlkmJee4E?si=kjMtNR1Hwe7NZ8as\n---\nSome pretty wild things in the meeting honestly, thanks to @JaneSmith for live tweeting.\n\nEg folks who were paid by the sponsor (big pharma) to speak on behalf of the product to be marketed did *not* have to declare they were being paid.\n---\n@JaneSmith Here is the full thread: https://twitter.com/JaneSmith/status/1798046087737180395\n---\n@JaneSmith Here the second vote on benefits and risks: https://twitter.com/FDAadcomms/status/1798107142219796794",
    "author": {
        "id": "16861042",
        "name": "John Doe",
        "username": "JohnDoe",
        "platformId": "twitter",
    },
    "quotedPosts": [
        {
            "url": "https://twitter.com/FDAadcomms/status/1798104612635070611",
            "content": "@JaneSmith #MDMAadcomm VOTE 1/2: Do the available data show that the drug is effective in patients with posttraumatic\nstress disorder?\n2-Yes\n9-No\n0-Abstain https://twitter.com/FDAadcomms/status/1798104612635070611/photo/1",
            "author": {
                "id": "148067168202752",
                "name": "FDAadcomms",
                "username": "FDAadcomms",
                "platformId": "twitter",
            },
        },
        {
            "url": "https://twitter.com/JaneSmith/status/1798046087737180395",
            "content": 'Next up on the AdComm agenda, when they come back from lunch at the top of hour, is the Open Public Hearing. For reasons mentioned below, don\'t be surprised if the "public" consists more of advocates for approval, and we hear from relatively few with reservations. https://twitter.com/JaneSmith/status/1797349211849245178',
            "author": {
                "id": "42893834",
                "name": "Jane Smith",
                "username": "JaneSmith",
                "platformId": "twitter",
            },
        },
        {
            "url": "https://twitter.com/FDAadcomms/status/1798107142219796794",
            "content": "@JaneSmith #MDMAadcomm VOTE 2/2: Do the benefits of midomafetamine with FDA’s proposed risk evaluation and mitigation strategy (REMS) outweigh its risks for the treatment of patients with PTSD?\n1-Yes\n10-No\n0-Abstain https://twitter.com/FDAadcomms/status/1798107142219796794/photo/1",
            "author": {
                "id": "1480844662752",
                "name": "FDAadcomms",
                "username": "FDAadcomms",
                "platformId": "twitter",
            },
        },
    ],
}


TEST_THREAD = {
    "author": {
        "id": "2111",
        "name": "Eiko Fried",
        "username": "Eiko Fried",
        "platformId": "twitter",
    },
    "url": "https://x.com/EikoFried/status/1798166869574398271",
    "thread": [
        {
            "content": "After careful consideration, the FDA advisory comission voted today 9:2 that MDMA has *not* been shown to be effective for treating PTSD, given massive concerns around validity threats in this literature. They also voted 10:1 that MDMA has *not* shown to be safe.",
            "url": "https://x.com/EikoFried/status/1798166869574398271",
            "quotedThread": {
                "author": {
                    "id": "2111",
                    "name": "FDAadcomms",
                    "username": "FDAadcomms",
                    "platformId": "twitter",
                },
                "url": "https://x.com/FDAadcomms/status/1798104612635070611",
                "thread": [
                    {
                        "content": "@eturnermd1 #MDMAadcomm VOTE 1/2: Do the available data show that the drug is effective in patients with posttraumatic\nstress disorder?\n2-Yes\n9-No\n0-Abstain https://twitter.com/FDAadcomms/status/1798104612635070611/photo/1",
                        "url": "https://x.com/FDAadcomms/status/1798104612635070611",
                        "quotedThread": None,
                    }
                ],
            },
        },
        {
            "content": "📄Many mentioned reasons overlap with those we summarized recently in our review paper: \nhttps://journals.sagepub.com/doi/10.1177/20451253231198466\n\n📺 I also summarize them for a lay audience in this YouTube video: \nhttps://www.youtube.com/watch?feature=youtu.be&si=kjMtNR1Hwe7NZ8as&v=WknlkmJee4E",
            "url": "https://x.com/EikoFried/status/1798167612175913332",
            "quotedThread": None,
        },
        {
            "content": "Some pretty wild things in the meeting honestly, thanks to @eturnermd1 for live tweeting.\n\nEg folks who were paid by the sponsor (big pharma) to speak on behalf of the product to be marketed did *not* have to declare they were being paid.",
            "url": "https://x.com/EikoFried/status/1798170515817013679",
            "quotedThread": None,
        },
        {
            "content": "@eturnermd1 Here is the full thread:",
            "url": "https://x.com/EikoFried/status/1798170610314715569",
            "quotedThread": {
                "author": {
                    "id": "2111",
                    "name": "Erick Turner @eturnermd1.bsky.social",
                    "username": "Erick Turner @eturnermd1.bsky.social",
                    "platformId": "twitter",
                },
                "url": "https://x.com/eturnermd1/status/1798046087737180395",
                "thread": [
                    {
                        "content": 'Next up on the AdComm agenda, when they come back from lunch at the top of hour, is the Open Public Hearing. For reasons mentioned below, don\'t be surprised if the "public" consists more of advocates for approval, and we hear from relatively few with reservations.',
                        "url": "https://x.com/eturnermd1/status/1798046087737180395",
                        "quotedThread": None,
                    }
                ],
            },
        },
        {
            "content": "@eturnermd1 Here the second vote on benefits and risks:",
            "url": "https://x.com/EikoFried/status/1798171316375445681",
            "quotedThread": {
                "author": {
                    "id": "2111",
                    "name": "FDAadcomms",
                    "username": "FDAadcomms",
                    "platformId": "twitter",
                },
                "url": "https://x.com/FDAadcomms/status/1798107142219796794",
                "thread": [
                    {
                        "content": "@eturnermd1 #MDMAadcomm VOTE 2/2: Do the benefits of midomafetamine with FDA’s proposed risk evaluation and mitigation strategy (REMS) outweigh its risks for the treatment of patients with PTSD?\n1-Yes\n10-No\n0-Abstain https://twitter.com/FDAadcomms/status/1798107142219796794/photo/1",
                        "url": "https://x.com/FDAadcomms/status/1798107142219796794",
                        "quotedThread": None,
                    }
                ],
            },
        },
    ],
}

EXAMPLE_REQUEST = {"post": SINGLE_QUOTE_TWEET, "parameters": {}}


def test_thread_interface():
    thread = AppThread.model_validate(TEST_THREAD_INTERFACE_1)
    assert len(thread.thread[0].quotedThread.thread) == 2


def test_thread_interface_conversion():
    thread = AppThread.model_validate(TEST_THREAD_INTERFACE_1)
    thread_ref_post = convert_thread_interface_to_ref_post(thread)
    assert thread_ref_post.posts[0].quoted_url == "https://example.com/post/2"
    assert (
        thread_ref_post.posts[0].quoted_post.url == thread_ref_post.posts[0].quoted_url
    )
    assert len(thread_ref_post.posts) == 2


def test_load_real_thread():
    thread = AppThread.model_validate(TEST_THREAD)
    thread_ref_post = convert_thread_interface_to_ref_post(thread)
    assert thread_ref_post.md_ref_urls() == [
        "https://x.com/FDAadcomms/status/1798104612635070611",
        "https://journals.sagepub.com/doi/10.1177/20451253231198466",
        "https://www.youtube.com/watch?feature=youtu.be&si=kjMtNR1Hwe7NZ8as&v=WknlkmJee4E",
        "https://x.com/eturnermd1/status/1798046087737180395",
        "https://x.com/FDAadcomms/status/1798107142219796794",
    ]


def test_author_platform_id_lowercase():
    author = Author(id="123", name="John Doe", username="johndoe", platformId="Twitter")
    assert author.platformId == "twitter"


def test_author_invalid_platform_id():
    with pytest.raises(ValidationError):
        Author(
            id="123", name="John Doe", username="johndoe", platformId=123
        )  # platformId should be a string


def test_app_post_normalize_content_urls():
    content = "Check out this tweet: https://twitter.com/user/status/1234567890"
    expected_content = "Check out this tweet: https://x.com/user/status/1234567890"
    post = AppPost(content=content)
    assert post.content == expected_content


def test_app_post_normalize_url():
    url = "https://twitter.com/user/status/1234567890"
    expected_url = "https://x.com/user/status/1234567890"
    post = AppPost(content="Test post", url=url)
    assert post.url == expected_url


def test_app_post_no_normalization_needed():
    content = "This is a test post with no Twitter URLs."
    url = "https://example.com"
    post = AppPost(content=content, url=url)
    assert post.content == content
    assert post.url == url


def test_app_thread_normalize_url():
    url = "https://twitter.com/user/status/1234567890"
    expected_url = "https://x.com/user/status/1234567890"
    author = Author(id="123", name="John Doe", username="johndoe", platformId="twitter")
    post = AppPost(content="Test post", url=url)
    thread = AppThread(author=author, thread=[post], url=url)
    assert thread.url == expected_url


def test_app_thread_author():
    author = Author(id="123", name="John Doe", username="johndoe", platformId="Twitter")
    post = AppPost(content="Test post")
    thread = AppThread(author=author, thread=[post])
    assert thread.author.name == "John Doe"
    assert thread.author.platformId == "twitter"


def test_i123():
    thread = AppThread.model_validate(TEST_POST_I123)
    thread_ref_post = convert_thread_interface_to_ref_post(thread)
    assert thread_ref_post.md_ref_urls() == [
        "https://x.com/fchollet/status/1810833882037825646"
    ]


if __name__ == "__main__":
    thread = AppThread.model_validate(TEST_POST_I123)
    thread_ref_post = convert_thread_interface_to_ref_post(thread)
    # pi = ParserInput(thread_post=thread_ref_post, max_posts=30)
    # proc_pi = preproc_parser_input(pi)
